The Annual Diabetes and Cancer Interface Symposium: Connecting the Dots
Diabetes and cancer are two of the major health scourges of the 21st century. Driven by interactions between genetics and the environment, these are diseases of metabolic disruption that greatly burden our lives. Research is focused on disease classification, prevention and treatment strategies that are tailored to the molecules and pathways that are dysregulated in affected individuals.
City of Hope is a unique organization with dual foci on cancer and diabetes that increasingly applies molecular tools at the interfaces of overweight, obesity, carcinogenesis, diabetogenesis and complications of treatments. The Arthur Riggs Diabetes & Metabolism Research Institute, is pleased to sponsor the annual Connecting the Dots Symposium, which brings together researchers and clinicians who are building expertise along the interfaces.
The third annual Connecting the Dots Symposium will take place virtually on Monday, November 14, 2022, from 8 a.m. to 1 p.m. PST. The keynote presentation will be given by Professor Marcus Goncalves of Weill Cornell Medicine in New York.
Please click the registration button below to attend the virtual symposium and opt-in for future announcements.
Please email email@example.com with any questions or to opt-out of receiving emails.
Thank you for your interest in the interfaces between diabetes and cancer!
Charles Brenner, Ph.D.
Alfred E. Mann Family Foundation Chair in Diabetes and Cancer Metabolism
Professor and Chair, Department of Diabetes & Cancer Metabolism
Beckman Research Institute of City of Hope
Debbie C. Thurmond, Ph.D.
Ruth B. & Robert K. Lanman Chair in Gene Regulation & Drug Discovery Research
Director, Arthur Riggs Diabetes & Metabolism Research Institute at City of Hope